Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.qmsmas.com | |
Market Cap | 241.96 Cr. | |
Enterprise Value(EV) | 275.10 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 3.57 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 37.93 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 82.09 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 42.25 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 3.21 | Calculated using Price: 135.55 |
Dividend Yield | 0.37 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.79 Cr. | 17,850,000 Shares |
FaceValue | 10 | |
About QMS Medical Allied Services Ltd. | ||
The company is an end to end provider of knowledge driven scientific solutions for the pharmaceutical industry’s marketing and outreach efforts. The company also deals in medical consumables such as disinfectants, filters, infection prevention tools, compression bandages, wound management dressing kits and dental products amongst others. |
1 Day |
|
+0.41% |
1 Week |
|
-3.90% |
1 Month |
|
-3.93% |
3 Month |
|
-6.52% |
6 Month |
|
-8.54% |
1 Year |
|
-39.05% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 99.46 | 102.03 | 73.44 | 41.62 | 12.58 | |
Return on Capital Employed (%) | 60.89 | 64.85 | 53.55 | 32.83 | 13.83 | |
Return on Assets (%) | 16.97 | 24.76 | 23.27 | 14.70 | 6.27 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 3 | 9 | 20 | 31 | 70 | 75 | |
Non Curr. Liab. | 1 | 2 | 2 | 1 | |||
Curr. Liab. | 15 | 24 | 39 | 52 | 46 | 42 | |
Minority Int. | |||||||
Equity & Liab. | 18 | 33 | 60 | 85 | 118 | 118 | |
Non Curr. Assets | 0 | 3 | 11 | 8 | 31 | 30 | |
Curr. Assets | 18 | 30 | 50 | 77 | 88 | 88 | |
Misc. Exp. not W/O | |||||||
Total Assets | 18 | 33 | 60 | 85 | 118 | 118 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 52 | 73 | 122 | 146 | 104 | |
Other Income | 0 | 0 | 0 | 1 | 1 | |
Total Income | 52 | 73 | 122 | 148 | 105 | |
Total Expenditure | -47 | -63 | -105 | -130 | -93 | |
PBIDT | 5 | 10 | 17 | 18 | 12 | |
Interest | 0 | -1 | -1 | -2 | -2 | |
Depreciation | 0 | 0 | -1 | -1 | -1 | |
Taxation | -1 | -2 | -4 | -4 | -2 | |
Exceptional Items | ||||||
PAT | 3 | 6 | 11 | 11 | 6 | |
Adjusted EPS | 2 | 4 | 7 | 7 | 4 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -4 | -3 | 2 | -2 | -8 | |
Cash Fr. Inv. | 0 | -4 | -8 | 2 | -25 | |
Cash Fr. Finan. | 5 | 7 | 7 | 0 | 32 | |
Net Change | 0 | 1 | 1 | 1 | -1 | |
Cash & Cash Eqvt | 0 | 1 | 1 | 2 | 1 |
No Corporate Announcement found. |
Fri, 08 Dec 2023 |
|
|
|
|
|